# Grand Pharmaceutical

销售用于肝癌选择性内放射治疗的钇-90微球产品（易甘泰®/SIR-Spheres），其美国DOORwaY90临床试验已在不可切除肝细胞癌适应症上达到主要终点；公司正在武汉建设中国最大的放射性药物生产基地。

Source: https://cn.bioecon.ru/companies/grand-pharmaceutical/
Updated: 2026-07-03

- 国家: China

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 营收 | 122.8亿港元(2025年) | https://flcube.com/?p=61514, https://newsfile.moomoo.com/public/NN-PersistNoticeAttachment/7781/20260326/12070908-0.PDF |
| 员工人数 | 12,614(截至2025年) | https://newsfile.moomoo.com/public/NN-PersistNoticeAttachment/7781/20260326/12070908-0.PDF, https://www.marketscreener.com/news/grand-pharmaceutical-group-limited-reports-earnings-results-for-the-full-year-ended-december-31-202-ce7e51dbd98ff621, https://www.morningstar.com.au/investments/security/HKSE/00512, https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0413/2026041301312.pdf |
| 生产基地 | 波士顿、法兰克福、新加坡及成都 | https://www.grandpharm.com/en/news/grand-pharmas-world-first-closed-loop-platform-nuclear-medicine-rd-and-production-base-is-about-to-be-put-into-operation/, https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0518/2025051800011.pdf, https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0413/2026041301312.pdf |
| 产能 | 成都基地拥有14条高标准GMP生产线 | https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0518/2025051800011.pdf, https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0413/2026041301312.pdf |
| 监管批准 | 获 FDA 批准用于不可切除肝细胞癌及结直肠癌肝转移 | https://allsci.com/news/clinical-trials/grand-pharmas-sir-spheres-y-90-aces-endpoints-in-hcc-phase-iii/, https://www.grandpharm.com/en/news/a-new-indication-of-grand-phamras-globally-innovative-radioactive-product-sir-spheres-y-90-resin-microsphere-injection-is-officially-approved-by-the-fda-ahead-of-schedule/, https://www.sirtex.com/us/news/press-releases/news-item?id=5517, https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0518/2025051800011.pdf, https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0413/2026041301312.pdf |
| 认证 | A级放射安全许可证（成都工厂） | https://www.grandpharm.com/en/news/grand-pharmas-world-first-closed-loop-platform-nuclear-medicine-rd-and-production-base-is-about-to-be-put-into-operation/, https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0518/2025051800011.pdf, https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0413/2026041301312.pdf |

独立来源: allsci.com, flcube.com, marketscreener.com, morningstar.com.au, newsfile.moomoo.com, sirtex.com, www1.hkexnews.hk

## 技术

- [放射性药物与诊疗一体化](https://cn.bioecon.ru/technology/radiopharmaceuticals-theranostics/)